Organization · Venture Capital
Genesis BioCapital
Genesis BioCapital is a venture capital firm based in Chattanooga, Tennessee, focused on creating and scaling biopharmaceutical companies that pursue transformative therapies for significant unmet medical needs. The firm employs a dual strategy of company formation and growth investing.
Overview
What Genesis BioCapital does
What Genesis BioCapital is
Genesis BioCapital is a venture capital firm based in Chattanooga, Tennessee, focused on creating and scaling biopharmaceutical companies that pursue transformative therapies for significant unmet medical needs. The firm employs a dual strategy of company formation and growth investing.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2024
- Approximate age
- About 2 years
- Structured capabilities
- Funder
- Last reviewed
- April 25, 2026
Official channels
Find Genesis BioCapital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Genesis BioCapital as a funder
Investment thesis
Genesis BioCapital focuses on creating and investing in biopharmaceutical companies that pursue transformative therapies for significant unmet medical needs, utilizing a dual strategy of company formation and growth investing.
Focus narrative
Genesis BioCapital primarily invests in seed and Series A stages, incubating companies from scientific discovery and investing in subsequent funding rounds. The firm is dedicated to advancing the field of biopharmaceuticals, particularly in areas such as precision medicine and genome engineering.
Value beyond capital
Genesis BioCapital adds value to its portfolio companies by providing scientific, operational, and clinical expertise, leveraging a highly experienced multidisciplinary team of biopharma executives and fund operators.
Focus and fit
- Stages
- Seed · Series A
- Regions
- North America
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 1
Portfolio context
Genesis BioCapital's notable portfolio company is KOMO Biosciences, which emerged from stealth in July 2024. KOMO focuses on precision genome engineering and has developed technology that enables the non-viral insertion of large genes into specific genome sites with high efficiency.
Common questions
What to know about Genesis BioCapital
Upseed classifies Genesis BioCapital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 25, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.